Your browser doesn't support javascript.
loading
Mortality due to non-AIDS-defining cancers among people living with HIV in Spain over 18 years of follow-up.
Suárez-García, I; Gutierrez, Félix; Pérez-Molina, José A; Moreno, Santiago; Aldamiz, Teresa; Valencia Ortega, Eulalia; Curran, Adrián; Gutiérrez González, Sara; Asensi, Víctor; Amador Prous, Concha; Jarrin, Inma; Rava, Marta.
Afiliação
  • Suárez-García I; Grupo de Enfermedades Infecciosas, Servicio de Medicina Interna, Hospital Universitario Infanta Sofía, FIIB HUIS HHEN, Madrid, Spain.
  • Gutierrez F; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.
  • Pérez-Molina JA; Department of Medicine, Universidad Europea de Madrid, Madrid, Spain.
  • Moreno S; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.
  • Aldamiz T; Hospital General Universitario de Elche and Universidad Miguel Hernández, Alicante, Spain.
  • Valencia Ortega E; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.
  • Curran A; Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.
  • Gutiérrez González S; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.
  • Asensi V; Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.
  • Amador Prous C; CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.
  • Jarrin I; Hospital Gregorio Marañón Servicio de Enfermedades Infecciosas/Microbiología Clínica Instituto de Investigación Gregorio Marañón, Madrid, Spain.
  • Rava M; Hospital Universitario La Paz, Madrid, Spain.
J Cancer Res Clin Oncol ; 149(20): 18161-18171, 2023 Dec.
Article em En | MEDLINE | ID: mdl-38008809
ABSTRACT

PURPOSE:

Our aim was to describe non-AIDS-defining cancer (NADC) mortality among people living with HIV (PLWH), to compare it with that of the general population, and to assess potential risk factors.

METHODS:

We included antiretroviral-naive PLWH from the multicentre CoRIS cohort (2004-2021). We estimated mortality rates and standardised mortality ratios (SMRs). We used cause-specific Cox models to identify risk factors.

RESULTS:

Among 17,978 PLWH, NADC caused 21% of all deaths observed during the follow-up. Mortality rate due to NADC was 1.58 (95%CI 1.36, 1.83) × 1000 person-years and lung and liver were the most frequent cancer-related causes of death. PLWH had 79% excess NADC mortality risk compared to the general population with the highest SMR found for Hodgkin lymphoma, anal and liver cancers. The SMRs decreased with age and were the highest in age groups under 50 years. The most important prognostic factor was low CD4 count, followed by smoking, viral hepatitis and HIV transmission through heterosexual contact or injection drug use.

CONCLUSION:

Non-AIDS cancers are an important cause of death among PLWH. The excess mortality related to certain malignancies and the association with immunodeficiency, smoking, and coinfections highlights the need for early detection and treatment of cancer in this population.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Infecções por HIV / Síndrome da Imunodeficiência Adquirida / Neoplasias Limite: Humans / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Hodgkin / Infecções por HIV / Síndrome da Imunodeficiência Adquirida / Neoplasias Limite: Humans / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2023 Tipo de documento: Article